Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Minerva Neurosciences, Inc. (NASDAQ: NERV) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Minerva Neurosciences, Inc. (NASDAQ: NERV) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Minerva Neurosciences GAAP EPS of $2.97 Nov. 05, 2024 7:37 AM ET By: Deepa Sarvaiya , SA News Editor [Seeking Alpha]
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates